These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 33986697)

  • 1. Informing About the Nocebo Effect Affects Patients' Need for Information About Antidepressants-An Experimental Online Study.
    Nestoriuc Y; Pan Y; Kinitz T; Weik E; Shedden-Mora MC
    Front Psychiatry; 2021; 12():587122. PubMed ID: 33986697
    [No Abstract]   [Full Text] [Related]  

  • 2. Minimizing Drug Adverse Events by Informing About the Nocebo Effect-An Experimental Study.
    Pan Y; Kinitz T; Stapic M; Nestoriuc Y
    Front Psychiatry; 2019; 10():504. PubMed ID: 31427995
    [No Abstract]   [Full Text] [Related]  

  • 3. Preventing adverse events of chemotherapy by educating patients about the nocebo effect (RENNO study) - study protocol of a randomized controlled trial with gastrointestinal cancer patients.
    Quidde J; Pan Y; Salm M; Hendi A; Nilsson S; Oechsle K; Stein A; Nestoriuc Y
    BMC Cancer; 2018 Sep; 18(1):916. PubMed ID: 30249191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' beliefs about placebo and nocebo effects in antidepressants - an online survey among German practitioners.
    Kampermann L; Nestoriuc Y; Shedden-Mora MC
    PLoS One; 2017; 12(5):e0178719. PubMed ID: 28562635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Informed Consent for Psychotherapy: Protocol for a Randomized Controlled Trial.
    Gerke L; Ladwig S; Pauls F; Trachsel M; Härter M; Nestoriuc Y
    JMIR Res Protoc; 2022 Sep; 11(9):e39843. PubMed ID: 36178713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study.
    Heisig SR; Shedden-Mora MC; Hidalgo P; Nestoriuc Y
    Health Psychol; 2015 Oct; 34(10):1033-1037. PubMed ID: 25689300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nocebo explanation and empathy on side-effect expectations of medication use following a fictional GP consultation.
    De Brochowski V; Rubin GJ; Webster RK
    Psychol Health Med; 2024 Apr; 29(4):809-821. PubMed ID: 37491019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Authorized Concealment to Minimize Nocebo Side Effects: A Survey of US Public Attitudes.
    Geers AL; Spotts EK; Vang M; Mayer SR; Miller FG
    Psychother Psychosom; 2023; 92(6):391-398. PubMed ID: 38043522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nocebo, informed consent and doctor-patient communication].
    Hansen E; Zech N; Benson S
    Nervenarzt; 2020 Aug; 91(8):691-699. PubMed ID: 32728796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible alleviation of symptoms and side effects through clinicians' nocebo information and empathy in an experimental video vignette study.
    Meijers MC; Stouthard J; Evers AWM; Das E; Drooger HJ; Jansen SJAJ; Francke AL; Plum N; van der Wall E; Nestoriuc Y; Dusseldorp E; van Vliet LM
    Sci Rep; 2022 Sep; 12(1):16112. PubMed ID: 36167876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel paradigm examining the remote induction of nocebo effects online.
    Barnes K; Nicholls K; Orlievsky S; Pei C; Elder C; Faasse K
    Health Psychol; 2024 Mar; 43(3):225-236. PubMed ID: 38010778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of placebo and nocebo mechanisms in depressive diseases and their treatment].
    Rief W
    Nervenarzt; 2020 Aug; 91(8):675-683. PubMed ID: 32607602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nocebo Effect: A Bias in Clinical Practice-An Ethical Approach.
    Răducan-Florea IV; Leaşu FG; Dinu EA; Rogozea LM
    Am J Ther; 2024 Sep-Oct 01; 31(5):e541-e549. PubMed ID: 38557480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Nocebo Effect and Informed Consent-Taking Autonomy Seriously.
    Gelfand S
    Camb Q Healthc Ethics; 2020 Apr; 29(2):223-235. PubMed ID: 32159495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Influence of Side Effect Information Framing on Nocebo Effects.
    Faasse K; Huynh A; Pearson S; Geers AL; Helfer SG; Colagiuri B
    Ann Behav Med; 2019 Jun; 53(7):621-629. PubMed ID: 30204841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nocebo phenomena in medicine: their relevance in everyday clinical practice.
    Häuser W; Hansen E; Enck P
    Dtsch Arztebl Int; 2012 Jun; 109(26):459-65. PubMed ID: 22833756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disentangling pharmacological and expectation effects in antidepressant discontinuation among patients with fully remitted major depressive disorder: study protocol of a randomized, open-hidden discontinuation trial.
    Meißner C; Warren C; Fadai T; Müller A; Zapf A; Lezius S; Ozga AK; Falkenberg I; Kircher T; Nestoriuc Y
    BMC Psychiatry; 2023 Jun; 23(1):457. PubMed ID: 37344789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nocebo effect and its relevance for clinical practice.
    Colloca L; Miller FG
    Psychosom Med; 2011 Sep; 73(7):598-603. PubMed ID: 21862825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.